Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges

Overview of attention for article published in Journal of Hematology & Oncology, July 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 8 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 4 additional patents.